KRpep-2d

KRpep-2d is a synthetic cyclic peptide designed to bind with high specificity to the RAS family of small GTPases, particularly KRAS. As a macrocyclic peptide, KRpep-2d exhibits enhanced conformational stability and protease resistance compared to linear peptides, making it an attractive molecular tool for research applications targeting protein-protein interactions. Its unique sequence and cyclization confer strong affinity for the active, GTP-bound conformation of KRAS, enabling researchers to probe signaling pathways that are otherwise difficult to modulate with small molecules. The development of KRpep-2d represents a significant advance in the field of peptide-based modulators for intracellular signaling proteins, supporting a range of studies in molecular biology, cancer research, and drug discovery.

Target validation: KRpep-2d is widely utilized in target validation studies focused on the RAS signaling pathway. By selectively binding to KRAS and interfering with its interaction partners, the peptide allows researchers to dissect the biological consequences of RAS inhibition in various cellular contexts. This capability is particularly valuable for elucidating the functional role of KRAS in oncogenic signaling, cell proliferation, and survival, thereby providing a foundation for evaluating the therapeutic potential of novel RAS-targeted interventions.

Protein-protein interaction studies: The macrocyclic structure and high affinity of KRpep-2d make it a robust tool for investigating protein-protein interactions involving KRAS. Researchers employ the peptide to disrupt the association between KRAS and its downstream effectors, such as RAF kinases, facilitating mechanistic studies of RAS-mediated signaling cascades. By enabling precise modulation of these interactions, KRpep-2d aids in mapping critical nodes within the signaling network and identifying new regulatory mechanisms.

Cellular pathway analysis: In cellular models, KRpep-2d is applied to modulate RAS activity and monitor downstream effects on signaling pathways such as MAPK/ERK and PI3K/AKT. The peptide's ability to penetrate cells and bind active KRAS allows for dynamic assessment of pathway activation, feedback regulation, and compensatory mechanisms. This application is instrumental in advancing systems-level understanding of RAS-driven cellular processes and in identifying biomarkers of pathway modulation.

Biochemical assay development: KRpep-2d serves as a valuable reagent in the development and optimization of biochemical assays designed to screen for RAS inhibitors or modulators. Its defined binding properties and specificity for KRAS-GTP complexes enable the establishment of competitive binding assays, fluorescence polarization assays, or surface plasmon resonance protocols. These assay platforms are essential for high-throughput screening and structure-activity relationship studies in early-stage drug discovery targeting the RAS pathway.

Structural biology: The unique binding mode of KRpep-2d to KRAS has facilitated structural biology investigations aimed at elucidating the conformational dynamics of RAS proteins. By stabilizing specific protein conformations, the peptide supports crystallography and NMR studies that reveal atomic-level details of the KRAS-peptide complex. Insights gained from these structural analyses inform rational design of next-generation RAS modulators and deepen scientific understanding of RAS function at the molecular level.

1. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

2. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

3. High fat diet and GLP-1 drugs induce pancreatic injury in mice

4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

5. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I